Escitalopram tablets are generally not carcinogenic when used correctly.
Escitalopram belongs to a selective 5-hydroxytryptamine reuptake inhibitor, has a good and stable antidepressant, anxiolytic, anti-obsessive-compulsive effect, mainly used in the treatment of depression, obsessive-compulsive disorder, generalized anxiety, panic disorder, somatization disorder, and neurasthenia and other psychological disorders, but also can be used to treat patients with premature ejaculation.
The dangers of long-term use of escitalopram cannot be generalized. If the doctor’s advice is strictly followed, there may be no harm; however, if the drug is taken for a long period of time, adverse reactions may occur, including dizziness, headache, drowsiness and joint pain.
In addition, animal studies have shown that an increased incidence of small bowel cancer was seen in rats at doses of 8 or 24 mg/kg/day, and when used in humans the dose is much lower than that, so its potential for causing cancer is low.
Escitalopram is prohibited for use in patients who are allergic to the drug or to any of the components of mirtazapine, in patients with cardiovascular disease, in persons under 18 years of age.
While taking escitalopram, patients need to monitor cardiac function, liver and kidney function, blood tests, blood sugar and blood lipids, and take the medication strictly according to the doctor’s recommendations.